Simon R. Platt
BVM&S, FRCVS, DACVIM (Neurology), DECVN
Dr. Platt runs a veterinary neurology consultancy service in addition to co-directing the teleneurology service of Vetoracle, a telemedicine company, and serving as medical director for Hallmarq Advanced Imaging.
Dr. Platt was a professor of neurology and neurosurgery at University of Georgia College of Veterinary Medicine until June 2022. His ongoing research interests include ischemic disease of the central nervous system, canine brain tumors, and epilepsy.
Dr. Platt is a member of the International Veterinary Epilepsy Task Force and a founding member and president of the Southeastern Veterinary Neurology Group. He is past president of the ACVIM (Neurology) and was a chief examiner for the ECVN. He has authored or coauthored more than 220 journal articles and 60 book chapters and is the co-editor of three textbooks: BSAVA Manual of Canine and Feline Neurology, Manual of Small Animal Neurological Emergencies, and Canine and Feline Epilepsy: Diagnosis and Management.
Dr. Platt received his veterinary degree from the University of Edinburgh (Scotland), completed an internship in small animal medicine and surgery at Ontario Veterinary College (University of Guelph), and completed a residency in neurology and neurosurgery at the University of Florida. He was awarded the Fellowship of the Royal College of veterinary Surgery based upon meritorious contributions to the profession.
Read Articles Written by Simon R. Platt
The medical field occasionally experiences moments that fundamentally change how disease is understood. The introduction of fluoxetine to human medicine in the late 1980s was one such moment. Before its arrival, depression and anxiety disorders in people were often poorly understood, heavily stigmatized, and treated with medications frequently associated with substantial adverse effects. Fluoxetine did more than offer a new treatment option; it helped transform public perception by framing many emotional and behavioral disorders as biologic diseases of the brain.
Veterinary medicine has undergone a remarkably similar journey. For decades, dogs that barked, destroyed furniture, or eliminated in the house when left alone were often viewed as disobedient or inadequately trained. Today, we recognize that many of these dogs are experiencing a physiologic panic response rather than a training deficit. In this issue, Dr. Melissa Bain’s “Pharmacologic Interventions for Canine Separation-Related Disorders” highlights how medications such as fluoxetine, clomipramine, trazodone, and newer agents can reduce the neurochemical cascade underlying panic and create the conditions necessary for successful behavior modification. Importantly, these medications are not substitutes for training; they are tools that enable learning.
The parallels with human psychiatry are striking. Modern veterinary psychopharmacology has helped practitioners recognize that behavior is deeply rooted in neurobiology. This movement from punishment to treatment, from blame to biology, represents one of the most significant advances in companion animal practice over the past several decades.
Subscribe to Research Wrapped on LinkedIn
Research Wrapped, from Today’s Veterinary Practice, is a monthly roundup of the scientific research that is most relevant to small animal veterinary practitioners. From findings on perianesthesia protocols for brachycephalic dogs to artificial intelligence interpretation of radiographs, this monthly email newsletter provides concise summaries that pull out the evidence-based clinical pearls veterinary practitioners need to keep delivering the highest standard of care. Now, you can subscribe to Research Wrapped as a LinkedIn newsletter.
